Public Sector Pension Investment Board (PSP Investments)
NBIX icon

Public Sector Pension Investment Board (PSP Investments)’s Neurocrine Biosciences NBIX Stock Holding History

Public Sector Pension Investment Board (PSP Investments)’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-45,000
Closed -$3.8M – 1460
2019
Q2 		$3.8M Sell
45,000
-38,000
-46% -$3.12M 0.03% 564
2019
Q1 		$7.31M Buy
+83,000
New +$6.94M 0.07% 234

Other funds holding NBIX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Public Sector Pension Investment Board (PSP Investments)'s NBIX Position: Q3 2019 in Review

Public Sector Pension Investment Board (PSP Investments) sold out of Neurocrine Biosciences (NBIX) in Q3 2019, closing a stake of 45,000 shares — an estimated $3.8M sold.

Public Sector Pension Investment Board (PSP Investments) first reported a position in NBIX in Q1 2019 and held it in 2 quarters. The position peaked at $7.31M in Q1 2019. 333 funds tracked by Wall St. Rank hold NBIX as of Q3 2019.

  • Public Sector Pension Investment Board (PSP Investments) reported no remaining Neurocrine Biosciences position as of Q3 2019 after selling out during the quarter.
  • Public Sector Pension Investment Board (PSP Investments) sold 45,000 Neurocrine Biosciences shares in Q3 2019, an estimated $3.8M.
  • Public Sector Pension Investment Board (PSP Investments) first reported a position in Neurocrine Biosciences in Q1 2019 and held it in 2 quarters.
  • Public Sector Pension Investment Board (PSP Investments)'s Neurocrine Biosciences position peaked at $7.31M in Q1 2019.
  • 333 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q3 2019.

Based on Public Sector Pension Investment Board (PSP Investments)'s 13F filing for Q3 2019, filed 14 Nov 2019.